CA2580100A1 - Traitement du dysfonctionnement endothelial chez les patients diabetiques - Google Patents

Traitement du dysfonctionnement endothelial chez les patients diabetiques Download PDF

Info

Publication number
CA2580100A1
CA2580100A1 CA002580100A CA2580100A CA2580100A1 CA 2580100 A1 CA2580100 A1 CA 2580100A1 CA 002580100 A CA002580100 A CA 002580100A CA 2580100 A CA2580100 A CA 2580100A CA 2580100 A1 CA2580100 A1 CA 2580100A1
Authority
CA
Canada
Prior art keywords
hdl
treatment
patient
infusion
diabetes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002580100A
Other languages
English (en)
Other versions
CA2580100C (fr
Inventor
Erik S.G. Stroes
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CSL Ltd
Original Assignee
CSL Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CSL Ltd filed Critical CSL Ltd
Priority to CA2580100A priority Critical patent/CA2580100C/fr
Publication of CA2580100A1 publication Critical patent/CA2580100A1/fr
Application granted granted Critical
Publication of CA2580100C publication Critical patent/CA2580100C/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA2580100A 2007-03-01 2007-03-01 Traitement du dysfonctionnement endothelial chez les patients diabetiques Active CA2580100C (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA2580100A CA2580100C (fr) 2007-03-01 2007-03-01 Traitement du dysfonctionnement endothelial chez les patients diabetiques

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA2580100A CA2580100C (fr) 2007-03-01 2007-03-01 Traitement du dysfonctionnement endothelial chez les patients diabetiques

Publications (2)

Publication Number Publication Date
CA2580100A1 true CA2580100A1 (fr) 2008-09-01
CA2580100C CA2580100C (fr) 2015-07-14

Family

ID=39731928

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2580100A Active CA2580100C (fr) 2007-03-01 2007-03-01 Traitement du dysfonctionnement endothelial chez les patients diabetiques

Country Status (1)

Country Link
CA (1) CA2580100C (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111184728A (zh) * 2020-02-20 2020-05-22 上海市儿童医院 海藻糖在肾病综合征中的应用

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111184728A (zh) * 2020-02-20 2020-05-22 上海市儿童医院 海藻糖在肾病综合征中的应用
CN111184728B (zh) * 2020-02-20 2023-04-04 上海市儿童医院 海藻糖在肾病综合征中的应用

Also Published As

Publication number Publication date
CA2580100C (fr) 2015-07-14

Similar Documents

Publication Publication Date Title
US8557962B2 (en) Treatment of endothelial dysfunction in diabetic patients
TWI515006B (zh) 重組ｖｗｆ調配物
KR101953494B1 (ko) 동결건조된 재조합 ｖｗｆ 제제
CA2398983C (fr) Combinaison pharmaceutique pour le traitement des dommages tissulaires dus au defaut d'irrigation arterielle
US20040038891A1 (en) Methods and compositions for the treatment of ischemic reperfusion
JP6431912B2 (ja) 臓器移植患者における抗体媒介性拒絶反応のｃ１−エステラーゼ阻害剤を使用した治療方法
EP3528820B1 (fr) Nouvelles formulations liposomales pegylées d'apeline pour le traitement de maladies liées au système cardiovasculaire
KR20100118104A (ko) 소생액
CA2580100C (fr) Traitement du dysfonctionnement endothelial chez les patients diabetiques
EP1964571B1 (fr) Traitement du dysfonctionnement endothélial chez les patients diabétiques
AU2007200908B2 (en) Treatment of endothelial dysfunction in diabetic patients
EP1968628A2 (fr) Transferrine et compositions a base de transferrine destinees au traitement du diabete
CN101254299B (zh) 糖尿病患者内皮机能不良的治疗
JP5601750B2 (ja) 糖尿病患者の内皮機能異常の治療
JP7265804B2 (ja) 代謝性障害の処置のための組換えタンパク質の使用
AU2019321654A1 (en) Compositions and methods for treatment of acute lung injury
Lerch Reconstituted, Plasma‐Derived High‐Density Lipoprotein

Legal Events

Date Code Title Description
EEER Examination request